Arteos II Study: Relationship Between Osteoporosis and Arterial Rigidity Within Fractured Patients Cohort (ARTEOS2)

June 15, 2016 updated by: Central Hospital, Nancy, France

Relationship Between Osteoporosis and Arterial Rigidity Within Fractured Patients Cohort.

The investigators planned to study relationship between osteoporosis and arterial rigidity within fractured patients cohort.

Study Overview

Status

Unknown

Conditions

Study Type

Observational

Enrollment (Anticipated)

300

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

  • France
      • Vandoeuvre, France, 54500
        • Recruiting
        • CHU de Brabois Endocrinology
        • Contact:
        • Contact:
        • Principal Investigator:
          • Georges WERYHA, Professor
        • Sub-Investigator:
          • Anna KEARNEY SCHWARTZ, Doctor
        • Sub-Investigator:
          • Anna ANGELOUSI, Doctor
        • Sub-Investigator:
          • Athanase BENETOS, Professor
        • Sub-Investigator:
          • Shiva KHORSAND, Doctor
        • Sub-Investigator:
          • Lelia GROZA, Doctor
        • Sub-Investigator:
          • Eva FEIGERLOVA, Doctor
        • Sub-Investigator:
          • Paolo SALVI, Professor

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Women and men > 60 years of age with medical history of low energy fracture andradiologic osteoporosis with DXA Tscore at -2,5 DS.

Description

Inclusion Criteria:

  • women and men > 60 years of age
  • medical history of low energy fracture
  • DXA Tscore -2,5 DS
  • FREE AND INFORMED CONSENT SIGNED

Exclusion Criteria:

  • women and men < 60 years of age
  • Corticoids treatment
  • Breast cancer or prostat cancer medical history
  • High energy fracture (traumatic fracture)
  • No social security affiliation
  • Incapacity to informed consent signed.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Central Hospital, Nancy, France

Investigators

  • Principal Investigator: Georges WERYHA, Professor, CHU de Brabois Endocrinology

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2012

Primary Completion (Anticipated)

April 1, 2017

Study Completion (Anticipated)

April 1, 2017

Study Registration Dates

First Submitted

April 26, 2012

First Submitted That Met QC Criteria

April 27, 2012

First Posted (Estimate)

April 30, 2012

Study Record Updates

Last Update Posted (Estimate)

June 16, 2016

Last Update Submitted That Met QC Criteria

June 15, 2016

Last Verified

June 1, 2016

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2011-A00453-38

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Osteoporosis

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in China

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe